Table 3 Quantitative results from the studies included in the present systematic review, according to distribution-based methods.
Analysis | PROM | Follow-up | Total score or domains | Power | MIDb |
|---|---|---|---|---|---|
Effect sizea | Australian Pelvic Floor Questionnaire | 6 weeks [49] | Bladder score | Authors did not specify if the effect size was small, medium or high | 1.5 |
Global score | 1.2 | ||||
Incontinence Impact Questionnaire (IIQ) | Unclear [42] | Total score | 0.2 | -19.9 | |
0.5 | -49.7 | ||||
International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) | Unclear [46] | Total score | 0.2 | -0.82 | |
0.5 | -2.05 | ||||
52 weeks (12 months) [48] | Total score | 0.5 | 1.7 | ||
International Consultation on Incontinence Questionnaire -Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) | 52 weeks (12 months) [48] | Total score | 0.5 | 5.2 | |
King’s Health Questionnaire (KHQ) | Unclear [47] | Total score | 0.8 | 10 | |
Michigan Incontinence Symptom Index (M-ISI) | Unclear [44] | Total score | 0.2 | 4.53 | |
Subscore: SUI | 1.79 | ||||
Subscore: UUI | 2.04 | ||||
Subscore: Pad use | 1.19 | ||||
Total score | 0.5 | 3.02 | |||
Subscore: SUI | 1.19 | ||||
Subscore: UUI | 1.36 | ||||
Subscore: Pad use | 0.79 | ||||
Urogenital Distress Inventory (UDI) | 12 weeks [41] | Total score | 0.2 | −8.1 (−8.8, −7.5)c | |
12 weeks [43] | -6 | ||||
Unclear [42] | -9.9 | ||||
Urogenital Distress Inventory (UDI) | 12 weeks [41] | Total score | 0.5 | −20.5 (−18.8, 21.9)c | |
12 weeks [43] | -16 | ||||
Unclear [42] | -24.8 | ||||
UDI-Subscale | Unclear [42] | Irritative subscale | 0.2 | -4.4 | |
0.5 | -10.9 | ||||
UDI-Subscale | 12 weeks [41] | Stress subscale | 0.2 | −3.9 (−4.2, −3.6)c | |
0.5 | −9.8 (−9.1, −10.6)c | ||||
Urinary Impact Questionnaire (UIQ) | 12 weeks [41] | Total score | 0.2 | −11.5 (−12.4, 10.7)c | |
0.5 | 28.7 (−26.7, 31.1)c | ||||
12 weeks [43] | 0.2 | -17 | |||
0.5 | -42 | ||||
Overactive Bladder Questionnaire (OAB-q) | Unclear [42] | Total score | 0.2 | 4.8 | |
0.5 | 12.1 | ||||
OAB-q: subscale | Unclear [42] | Symptom severity | 0.2 | -4.2 | |
0.5 | -10.4 | ||||
Standardized response mean | Australian Pelvic Floor Questionnaire | 6 weeks [49] | Bladder score | NA | 1.4 |
Global score | 1.3 | ||||
Standard error of measurement | Incontinence Impact Questionnaire (IIQ) | Unclear [42] | Total score | NA | -18.2 |
Urogenital Distress Inventory (UDI) | 12 weeks [41] | Total score | NA | −15.3 (−14.2, 16.4)c | |
12 weeks [43] | -11 | ||||
Unclear [42] | -22.1 | ||||
UDI-Subscale | 12 weeks [41] | Irritative subscale | NA | −11.7 (−10.9, 12.6)c | |
Unclear [42] | -11.9 | ||||
UDI-Subscale | 12 weeks [41] | Stress subscale | NA | −13.1 (−12.3, −13.9) c | |
Urinary Impact Questionnaire (UIQ) | 12 weeks [41] | Total score | NA | −11.7 (−10.9, 12.6) c | |
12 weeks [43] | -15 | ||||
Overactive Bladder Questionnaire (OAB-q) | Unclear [42] | Total score | NA | 4.3 | |
OAB-q-Subscale | Unclear [42] | Symptom severity | -7.5 |